Religare Enterprises Ltd on Monday refuted the allegations levelled against its Chairman Rashmi Saluja with regard to excessive remuneration, terming those as 'completely false and erroneous'.
The statement comes within days of proxy advisory firm InGovern Research alleging that Saluja was paid excessive remuneration.
Religare said the performance-linked remuneration was paid to Saluja after approval of the Nomination and Remuneration Committee, Board, and the shareholders of REL.
"The allegation that the executive chairperson draws a remuneration of more than Rs 150 crore per annum is completely false and erroneous. As per the annual report for FY 22-23 of REL, the remuneration for the Executive Chairperson was Rs 8.12 crore. Even after including the perquisites value of the ESOPs, it reached a figure of Rs 42.06 crore," Religare said in a statement.
It further said that Saluja was reappointed as the Executive Chairperson in Feb. 2023 for a second term for a five-year period through a resolution by the Board and approval of shareholders.
Religare further said that Saluja was instrumental in creating value for all the shareholders of REL. The share price of REL, which saw a low of Rs 17 in 2020, rose to a high of Rs 280 in Sept. 2023.
"The ESOP perquisite value is also reflective of this significant value creation a part of which was also shared by her as a shareholder/employee of the company," Religare added.
Currently, Religare management is engaged in a tussle with the Burman family-- promoters of FMCG major Dabur India.
Burman family which has hiked its stake in Religare through creeping acquisition to around 26%, is now proposing to make an open offer for acquiring another 25% stake in the financial services company.
As per market regulator Sebi rules, it is mandatory for a company to make an open offer of 26% to all shareholders.
Religare also denied that the Burman family, at a meeting on Sept. 20, had informed Saluja of a proposed open offer.
The Burman family, it may be mentioned, had announced an open offer to buy additional share of REL at Rs 235 apiece, amounting to a total consideration of up to Rs 2,115 crore in cash.
Religare had objected to the open offer price and sought an independent valuation report.
On allegations that Saluja had liquidated the ESOPs after meeting a representative of the Burman family on Sept. 20, the Religare statement said, "The process of liquidation of ESOPs through financing and sale was set in motion several days before the said meeting."
The actual sale, it added, happened on Sept. 21 and 22 at the prevalent market price and the share sale proceeds were utilised to further invest in Religare group entity.
RECOMMENDED FOR YOU
![](https://images.assettype.com/bloombergquint/2024-09-05/r5ruwc7f/Web_story_dimensions___2023_05_08T153451_852 (4).png?rect=0%2C0%2C3500%2C1969&auto=format%2Ccompress&format=webp&w=75)
Stock Market Highlights: Sensex, Nifty Gainers And Losers — Sept 5
![timelogo](/images/amp-time.png)
![](https://images.assettype.com/bloombergquint/2024-08-23/5i3qzxbd/1690728729308.jpg?rect=0%2C0%2C3500%2C1969&auto=format%2Ccompress&format=webp&w=75)
ED Searches Residences Of Top Executives Of Religare Enterprises
![timelogo](/images/amp-time.png)
![](https://images.assettype.com/bloombergquint/2024-08-22/2yrxakx3/Screenshot (26).png?rect=0%2C0%2C3500%2C1969&auto=format%2Ccompress&format=webp&w=75)
Premier Energies To Use IPO Proceeds To Build Hyderabad Solar Plant
![timelogo](/images/amp-time.png)
![](https://images.assettype.com/bloombergquint/2024-04/6dcfa79e-87fd-491a-930b-92f036e3933c/Building_Image.jpg?rect=0%2C0%2C3500%2C1969&auto=format%2Ccompress&format=webp&w=75)
IRDAI Orders Care Health To Repurchase ESOPs Granted To Chairperson Rashmi Saluja
![timelogo](/images/amp-time.png)